Interaction Checker

Two additional drugs now available on the interaction checker

Wednesday 20 December 2017

Idelalisib and rituximab are now listed in the interaction checker as cancer drugs and interactions can be found with all the comedications. 

  • Idelalisib (Zydelig®) is a phosphoinositide 3-kinase inhibitor and is indicated for the treatment of chronic lymphocytic B-cell leukemia and non-Hodgkin lymphoma.
  • Rituximab (MabThera®, Truxima®, Rituxan®) is a monoclonal antibody and is indicated for the treatment of chronic lymphocytic B-cell leukemia and non-Hodgkin lymphoma.
ENDORSED BY
Bopa